Key result
Transgenic mice overexpressing Cyclophilin A displayed 2.5- to 3.8-fold stronger disease resistance to influenza A virus infection compared to wild-type animals.
Why the study?
Does overexpression of Cyclophilin A protect mice against influenza A virus infection?
Does overexpression of Cyclophilin A protect mice against influenza A virus infection?
Overexpression of Cyclophilin A in mice confers significant resistance to influenza A virus infection by reducing viral replication and modulating immune responses.
This is the authors' abstract. We don't add key points for this paper.
Our previous studies indicate that Cyclophilin A (CypA) impairs the replication of influenza A virus in vitro. To further evaluate the antiviral functions of CypA and explore its mechanism, transgenic mice with overexpression of CypA by two specific promoters with SPC (CypA-SPC) or CMV (CypA-CMV) were developed. After challenge with the A/WSN/33(H1N1) influenza virus, CypA-SPC and CypA-CMV transgenic mice displayed nearly 2.5- and 3.8-fold stronger disease resistance to virus infection, respectively, compared to wild-type animals. Virus replication, pathological lesions and inflammatory cytokines were substantially reduced in both lines of transgenic mice. In addition, after infection there was an upregulation of genes associated with cell migration, immune function, and organ development; and a downregulation of genes associated with the positive regulation of immune cells and apoptosis in the peritoneal macrophages of CypA-overexpressing transgenic mice (CypA+). These results indicate that CypA is a key modulator of influenza virus resistance in mice, and that CypA+ mice constitutes an important model to study the roles of CypA in the regulation of immune responses and infections.
Answers are grounded in this paper and cite their sources.
Animal data suggest Cyclophilin A as antiviral target; leaves open human translation and trials.
No takes yet. Share an insight, caveat, or question.
Li et al. (2016) studied Influenza A virus infection. Cyclophilin A overexpression (CypA-SPC or CypA-CMV) vs. Wild-type C57BL/6 mice was evaluated on 50% median lethal dose (MLD50) (3.8-fold increase (CypA-CMV) and 2.5-fold increase (CypA-SPC)). Transgenic mice overexpressing Cyclophilin A displayed 2.5- to 3.8-fold stronger disease resistance to influenza A virus infection compared to wild-type animals.
Synapse has enriched 10 related papers. Consider them for comparative context: